Results 201 to 210 of about 382,920 (355)

Smoldering Multiple Myeloma: Early Intervention or Structured Surveillance? A Comprehensive Review of Evidence for and Against Early Therapy. [PDF]

Cancers (Basel)
Arora K, Soueid L, Williams L, Grover J, Basali D, Khouri J, Kaushal Y, Mazzoni S, Dahiya R, Faiman B, Valent J, Anwer F, Raza S.   +12 more
europepmc   +1 more source

Myeloma of the mandible

, 2016
Ian Bickle
openalex   +1 more source

Clinical Implications of Complex Pharmacokinetics for Daratumumab Dose Regimen in Patients With Relapsed/Refractory Multiple Myeloma [PDF]

, 2016
XS Xu, Xiaoyu Yan, Thomas A. Puchalski, Sagar Lonial, HM Lokhorst, PM Voorhees, Trine Lindhardt Plesner, Kui Liu, Imran Khan, R Jansson, Tahamtan Ahmadi, Juan José Pérez Ruixo, Honghui Zhou, Pamela L. Clemens   +13 more
openalex   +1 more source

Extramedullary myeloma progressed to plasmablastic myeloma

Clinical Hematology International
Ke Xu, Charalampia Kyriakou
openaire   +2 more sources

Bioinorganic Site‐Specific Conjugation of Multi‐Arm Linkers to Create Pharmaceuticals With Targeting and Effector Functions

Journal of the Chinese Chemical Society, EarlyView.
This Account showcases a modular, multi‐arm linker platform that decouples payload loading from antibody conjugation. By leveraging a computationally designed ACPGHA zinc‐binding motif, we demonstrate the construction of homogeneous antibody‐drug conjugates and theranostic antibody‐radionuclide conjugates with high payload loading. The multi‐arm linker
Cédric Grauffel, Tse Wen Chang, Carmay Lim   +2 more
wiley   +1 more source

Microenvironmental Drivers of Bone Disease in Multiple Myeloma: Oxidative Stress, Sterile Inflammation, Autophagy-Lysosomal Remodeling, and the Iron-Lipid Peroxidation Axis. [PDF]

Biomolecules
Nasso ME, Bottaro A, Fazio M, Stagno F, Gangemi S, Allegra A.   +5 more
europepmc   +1 more source

Phase I/II study exploring ImMucin, a pan‐major histocompatibility complex, anti‐MUC1 signal peptide vaccine, in multiple myeloma patients [PDF]

, 2014
Lior Carmon, Irit Avivi, Riva Kovjazin, Tsila Zuckerman, Lillian Dray, Moshe E. Gatt, Reuven Or, Michael Y. Shapira   +7 more
openalex   +1 more source

Molecular Functions and Drug Prediction of MMP1 and TGFBR2 in Nasopharyngeal Carcinoma

Journal of Clinical Laboratory Analysis, EarlyView.
MMP1 and TGFBR2 were validated by machine learning and external datasets as the candidate genes. Dexamethasone showed strong binding affinity to MMP1 (−7.72 kcal/mol) and TGFBR2 (−7.27 kcal/mol) in docking studies. Knockdown of MMP1 repressed the malignant phenotypes of NPC cells.
Feng Wang, Binbin Ge, Ming Li, Xiaochun Xia, Fuming Zhang, Pengqin Xu   +5 more
wiley   +1 more source

International uniform response criteria for multiple myeloma

Leukemia, 2006
B. Durie, J. Harousseau, J. Miguel, J. Bladé, B. Barlogie, K. Anderson, M. Gertz, M. Dimopoulos, J. Westin, P. Sonneveld, H. Ludwig, G. Gahrton, M. Beksaç, J. Crowley, A. Belch, M. Boccadaro, I. Turesson, D. Joshua, D. Vesole, R. Kyle, R. Alexanian, G. Tricot, M. Attal, G. Merlini, R. Powles, P. Richardson, K. Shimizu, P. Tosi, G. Morgan, S. Rajkumar, on behalf of the Polish Adult Leukaemia Group   +30 more
semanticscholar   +1 more source

Smoldering multiple myeloma in transition: redefining early myeloma in the modern era. [PDF]

Leukemia
Landgren O.
europepmc   +1 more source